ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,160,000 | -8.9% | 70,900 | +34.8% | 0.02% | -20.0% |
| Q1 2022 | $1,274,000 | -5.1% | 52,611 | -8.6% | 0.02% | -28.6% |
| Q4 2021 | $1,343,000 | -7.8% | 57,560 | -3.6% | 0.04% | +29.6% |
| Q2 2021 | $1,456,000 | +52.6% | 59,698 | +61.5% | 0.03% | +68.8% |
| Q1 2021 | $954,000 | -70.6% | 36,976 | -53.0% | 0.02% | -83.5% |
| Q3 2020 | $3,242,000 | -14.9% | 78,600 | 0.0% | 0.10% | -46.7% |
| Q2 2020 | $3,810,000 | – | 78,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |